ClinicalTrials.gov
ClinicalTrials.gov Menu

Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01414959
Recruitment Status : Completed
First Posted : August 11, 2011
Last Update Posted : August 29, 2017
Sponsor:
Information provided by (Responsible Party):
Markus Zeitlinger, Medical University of Vienna

Brief Summary:
The investigators will measure the pharmacokinetics of doripenem in skeletal muscle, subcutaneous adipose tissue, bronchoalveolar lavage and plasma of intubated intensive care patients.

Condition or disease
Pneumonia Abdominal Infection Urinary Tract Infection

Detailed Description:
Methods: microdialysis, blood sampling, bronchoalveolar lavage

Study Type : Observational
Actual Enrollment : 16 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients
Study Start Date : August 2011
Actual Primary Completion Date : July 2013
Actual Study Completion Date : July 2013



Biospecimen Retention:   Samples Without DNA
plasma broncheoalvoeolar lavage microdialysates


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
intubated patients, intensive care
Criteria

Inclusion Criteria:

  • endotracheal intubation; pneumonia or complicated abdominal infection or complicated urinary tract infection

Exclusion Criteria:

  • allergy to doripenem, hemodialysis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01414959


Locations
Austria
Med. Univ. of Vienna
Vienna, Austria, 1090
Sponsors and Collaborators
Medical University of Vienna
Investigators
Principal Investigator: Markus Zeitlinger, MD Medical Universit of Vienna

Responsible Party: Markus Zeitlinger, Professor Dr., Medical University of Vienna
ClinicalTrials.gov Identifier: NCT01414959     History of Changes
Other Study ID Numbers: Dori_MD_ICU
First Posted: August 11, 2011    Key Record Dates
Last Update Posted: August 29, 2017
Last Verified: August 2017

Keywords provided by Markus Zeitlinger, Medical University of Vienna:
intensive care patient
intubation
(please change wording as you like!)

Additional relevant MeSH terms:
Infection
Communicable Diseases
Pneumonia
Urinary Tract Infections
Intraabdominal Infections
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Urologic Diseases